Zentralbl Chir 2014; 139(S 01): S22-S26
DOI: 10.1055/s-0034-1382886
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Perioperative Antibiotikatherapie in der Thoraxchirurgie

Perioperative Antibiotic Therapy in Thoracic Surgery
M. Ried
1   Abteilung für Thoraxchirurgie, Universitätsklinikum Regensburg, Deutschland
,
H.-S. Hofmann
1   Abteilung für Thoraxchirurgie, Universitätsklinikum Regensburg, Deutschland
2   Klinik für Thoraxchirurgie, Krankenhaus Barmherzige Brüder Regensburg, Deutschland
› Author Affiliations
Further Information

Publication History

Publication Date:
29 September 2014 (online)

Zusammenfassung

Hintergrund: Bisher existieren in Deutschland keine offiziellen Leitlinien für eine spezielle perioperative Antibiotikaprophylaxe (PAP) in der Thoraxchirurgie. In dieser Übersichtsarbeit werden sowohl die vorhandenen Daten zur PAP als auch zur antibiotischen Therapie der postoperativen Pneumonie (POP) in der Thoraxchirurgie dargestellt. Material und Methoden: Selektive Literaturrecherche in Medline und Empfehlungen der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) sowie der Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. (PEG). Ergebnisse: Die PAP ist eine kurzfristige, im Allgemeinen einmalige Gabe eines Antibiotikums vor oder in Ausnahmefällen spätestens während eines operativen Eingriffs. Durch eine PAP mit Cephalosporinen der 1. oder 2. Generation konnte die Rate an postoperativen Wundinfektionen nach thoraxchirurgischen Eingriffen signifikant gesenkt werden. In diesen wenigen randomisierten Studien konnte bisher jedoch kein eindeutiger Effekt der PAP auf die postoperative Rate an Pneumonien oder Empyemen nachgewiesen werden. Eine POP tritt in bis zu 20–25 % der Fälle nach größeren thoraxchirurgischen Operationen auf. Die antibiotische Therapie der POP sollte frühzeitig und nach Antibiogramm erfolgen. Schlussfolgerung: Basierend auf wenigen prospektiven, randomisierten Studien wird eine Empfehlung zur einmaligen intravenösen PAP mit Cephalosporinen bei thoraxchirurgischen Operationen ausgesprochen. Die Therapie der POP sollte neben allgemeinen Maßnahmen eine intravenöse antibiotische Therapie nach Antibiogramm beinhalten.

Abstract

Introduction: In Germany no official guidelines exist for a specific perioperative antibiotic prophylaxis (PAP) in thoracic surgery. In this review, data regarding the PAP as well as antibiotic therapy of the postoperative pneumonia (POP) in thoracic surgery are described. Methods: Selective literature researches were carried out in Medline with consideration of the official recommendations of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) as well as Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. (PEG). Results: The PAP is defined as a short and single application of an antibiotic agent preoperatively or during a surgical intervention. A PAP with first-generation or second-generation cephalosporins could significantly reduce the rate of surgical site infections after thoracic surgery. However, these few randomised trials could not demonstrate a distinct effect on the rate of POP and postoperative empyema. The incidence of POP is approximately 20–25 % after major thoracic surgery. Antibiotic therapy of POP should be performed early and be based on antibiotic sensitivity. Conclusion: Based on the few prospective, randomised studies a single dose of intravenous PAP with a cephalosporin is recommended in thoracic surgery. Therapy of the POP should include general procedures combined with a specific antibiotic therapy according to antibiotic sensitivity.

 
  • Literatur

  • 1 Gastmeier P, Geffers C. Nosokomiale Infektionen in Deutschland: wie viele gibt es wirklich?. Dtsch Med Wochenschr 2008; 133: 1111-1115
  • 2 Horan TC, Gaynes TP, Martone WJ et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13: 606-608
  • 3 Arbeitskreis Krankenhaus- und Praxishygiene der AWMF. Perioperative Antibiotikaprophylaxe: AWMF-Register Nr. 029-022/Klasse: S1+IDA. Hyg Med 2012; 37: 88-91
  • 4 Wacha H, Hoyme U, Isenmann R et al. Perioperative Antibiotika-Prophylaxe. Empfehlungen einer Expertenkommission der Paul-EhrlichGesellschaft für Chemotherapie e. V. Chemother J 2010; 19: 70-84
  • 5 Edwards FH, Engelman RM, Houck P et al. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg 2006; 81: 397-404
  • 6 Chang SH, Krupnick AS. Perioperative antibiotics in thoracic surgery. Thorac Surg Clin 2012; 22: 35-45
  • 7 Bernard A, Pillet M, Goudet P et al. Antibiotic prophylaxis in pulmonary surgery. A prospective randomized double blind trial of flash cefuroxime versus forty-eight-hour cefuroxime. J Thorac Cardiovasc Surg 1994; 107: 896-900
  • 8 Nichols RL. Preventing surgical site infections: a surgeonʼs perspective. Emerg Infect Dis 2001; 7: 220-224
  • 9 Nichols RL. Preventing surgical site infections. Clin Med Res 2004; 2: 115-118
  • 10 Cruse PJE, Ford R. The epidemiology of wound infection. A 10-year old prospective study of 62,939 wounds. Surg Clin North Am 1980; 60: 27-40
  • 11 Mangram AJ, Horan TC, Pearson ML et al. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999; 20: 250-278
  • 12 Bernard A, Ferrand L, Hagry O et al. Identification of prognostic factors determining risk groups for lung resection. Ann Thorac Surg 2000; 70: 1161-1167
  • 13 Nan DN, Fernández-Ayala M, Fariñas-Alvarez C et al. Nosocomial infection after lung surgery: incidence and risk factors. Chest 2005; 128: 2647-2652
  • 14 Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189: 395-404
  • 15 Cameron JL, Imbembo A, Kieffer RF et al. Prospective clinical trial of antibiotics for pulmonary resection. Surg Gynecol Obstet 1981; 152: 156-158
  • 16 Frimodt-Moller N, Ostri P, Pedersen I et al. Antibiotic prophylaxis in pulmonary surgery: a double-blind study of penicillin versus placebo. Ann Surg 1982; 195: 444-450
  • 17 Ilves R, Cooper J, Todd T et al. Prospective, randomized, double-blind study using prophylactic cephalothin for major, elective, general thoracic operations. J Thorac Cardiovasc Surg 1981; 81: 813-817
  • 18 Aznar R, Mateu M, Miro JM et al. Antibiotic prophylaxis in non-cardiac thoracic surgery: Cefazolin versus placebo. Eur J Cardiothorac Surg 1991; 5: 515-518
  • 19 Schussler O, Dermine H, Alifano M et al. Should we change antibiotic prophylaxis for lung surgery? Postoperative pneumonia is the critical issue. Ann Thorac Surg 2008; 86: 1727-1733
  • 20 Turna A, Kutlu CA, Ozalp T et al. Antibiotic prophylaxis in elective thoracic surgery: cefuroxime versus cefepime. Thorac Cardiovasc Surg 2003; 51: 84-88
  • 21 Rogers ML, Taylor R, Beggs FD. Antibiotic prophylaxis in general thoracic surgery in the UK. Eur J Cardiothorac Surg 2000; 18: 375-376
  • 22 Hawn MT, Richman JS, Vick CC et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg 2013; 148: 649-657
  • 23 Oxman DA, Issa NC, Marty FM et al. Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial. JAMA Surg 2013; 148: 440-446
  • 24 Harbarth S, Samore MH, Lichtenberg D et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101: 2916-2921
  • 25 Engelman R, Shahian D, Shemin R et al. The Society of Thoracic Surgeons Practice Guideline Series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg 2007; 83: 1569-1576
  • 26 American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. Am J Respir Crit Care Med 1995; 153: 1711-1725
  • 27 Yaffe MB, Fink MP. Hospital-acquired pneumonia in the postoperative setting. Sem Respir Crit Care Med 1997; 18: 121-132
  • 28 Unertl K, Heininger A. Prävention der nosokomialen Pneumonie: Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert-Koch-Institut. Bundesgesundheitsbl 2000; 43: 302-309
  • 29 Radu DM, Jauréguy F, Seguin A et al. Postoperative pneumonia after major pulmonary resections: an unsolved problem in thoracic surgery. Ann Thorac Surg 2007; 84: 1669-1673
  • 30 Boldt J, Piper S, Uphus D et al. Preoperative microbiologic screening and antibiotic prophylaxis in pulmonary resection operations. Ann Thorac Surg 1999; 68: 208-211
  • 31 Olak J, Jeyasingham K, Forrester-Wood C et al. Randomized trial of one-dose versus six-dose cefazolin prophylaxis in elective general thoracic surgery. Ann Thorac Surg 1991; 51: 956-958
  • 32 Kappstein I, Schulgen G, Richtmann R et al. Prospektive Untersuchung zur Verlängerung der Krankenhausverweildauer durch nosokomiale Pneumonie und Wundinfektion in einem Universitätsklinikum. Dtsch Med Wochenschr 1991; 116: 281-287
  • 33 Duque JL, Ramos G, Castrodeza J et al. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Ann Thorac Surg 1997; 63: 944-950
  • 34 Sok M, Dragas AZ, Erzen J et al. Sources of pathogens causing pleuropulmonary infections after lung resection. Eur J Cardiothorac Surg 2002; 22: 23-29
  • 35 Schussler O, Alifano M, Dermine H et al. Postoperative pneumonia after major lung resection. Am J Respir Crit Care Med 2006; 173: 1161-1169
  • 36 Roberts JR, Eustis C, Devore R et al. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 2001; 72: 885-888
  • 37 Shiono S, Yoshida J, Nishimura M et al. Risk factors of postoperative respiratory infections in lung cancer surgery. J Thorac Oncol 2007; 2: 34-38
  • 38 Cao C, Manganas C, Ang SC et al. Video-assisted thoracic surgery versus open thoracotomy for non-small cell lung cancer: a meta-analysis of propensity score-matched patients. Interact Cardiovasc Thorac Surg 2013; 16: 244-249
  • 39 Roberts JR, Shyr Y, Christian KR et al. Preemptive gastrointestinal tract management reduces aspiration and respiratory failure after thoracic operations. J Thorac Cardiovasc Surg 2000; 119: 449-452
  • 40 Muehling BM, Halter GL, Schelzig H et al. Reduction of postoperative pulmonary complications after lung surgery using a fast track clinical pathway. Eur J Cardiothorac Surg 2008; 34: 174-180
  • 41 Montravers P, Veber B, Auboyer C et al. Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of the Eole study. Crit Care Med 2002; 30: 368-375
  • 42 Belda J, Cavalcanti M, Ferrer M et al. Bronchial colonization and postoperative respiratory infections in patients undergoing lung cancer surgery. Chest 2005; 128: 1571-1579
  • 43 Sziklavari Z, Grosser C, Neu R et al. Minimally invasive vacuum-assisted closure therapy in the management of complex pleural empyema. J Cardiothorac Surg 2013; 17: 49-53
  • 44 Foroulis CN, Kleontas A, Karatzopoulos A et al. Early reoperation performed for the management of complications in patients undergoing general thoracic surgical procedures. J Thorac Dis 2014; 6: 21-31